Cargando…

Comparison of Positron Emission Tomography Using 2-[(18)F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[(18)F]-fluorothymidine in Lung Cancer Imaging

BACKGROUND: The detection of solitary pulmonary nodules (SPNs) that may potentially develop into a malignant lesion is essential for early clinical interventions. However, grading classification based on computed tomography (CT) imaging results remains a significant challenge. The 2-[(18)F]-fluoro-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fu-Li, Tan, Ye-Ying, Gu, Xiang-Min, Li, Tian-Ran, Lu, Guang-Ming, Liu, Gang, Huo, Tian-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198527/
https://www.ncbi.nlm.nih.gov/pubmed/27958224
http://dx.doi.org/10.4103/0366-6999.195468
_version_ 1782488865044430848
author Wang, Fu-Li
Tan, Ye-Ying
Gu, Xiang-Min
Li, Tian-Ran
Lu, Guang-Ming
Liu, Gang
Huo, Tian-Long
author_facet Wang, Fu-Li
Tan, Ye-Ying
Gu, Xiang-Min
Li, Tian-Ran
Lu, Guang-Ming
Liu, Gang
Huo, Tian-Long
author_sort Wang, Fu-Li
collection PubMed
description BACKGROUND: The detection of solitary pulmonary nodules (SPNs) that may potentially develop into a malignant lesion is essential for early clinical interventions. However, grading classification based on computed tomography (CT) imaging results remains a significant challenge. The 2-[(18)F]-fluoro-2-deoxy-D-glucose ((18)F-FDG) positron emission tomography (PET)/CT imaging produces both false-positive and false-negative findings for the diagnosis of SPNs. In this study, we compared (18)F-FDG and 3-deoxy-3-[(18)F]-fluorothymidine ((18)F-FLT) in lung cancer PET/CT imaging. METHODS: The binding ratios of the two tracers to A549 lung cancer cells were calculated. The mouse lung cancer model was established (n = 12), and micro-PET/CT analysis using the two tracers was performed. Images using the two tracers were collected from 55 lung cancer patients with SPNs. The correlation among the cell-tracer binding ratios, standardized uptake values (SUVs), and Ki-67 proliferation marker expression were investigated. RESULTS: The cell-tracer binding ratio for the A549 cells using the (18)F-FDG was greater than the ratio using (18)F-FLT (P < 0.05). The Ki-67 expression showed a significant positive correlation with the (18)F-FLT binding ratio (r = 0.824, P < 0.01). The tumor-to-nontumor uptake ratio of (18)F-FDG imaging in xenografts was higher than that of (18)F-FLT imaging. The diagnostic sensitivity, specificity, and the accuracy of (18)F-FDG for lung cancer were 89%, 67%, and 73%, respectively. Moreover, the diagnostic sensitivity, specificity, and the accuracy of (18)F-FLT for lung cancer were 71%, 79%, and 76%, respectively. There was an obvious positive correlation between the lung cancer Ki-67 expression and the mean maximum SUV of (18)F-FDG and (18)F-FLT (r = 0.658, P < 0.05 and r = 0.724, P < 0.01, respectively). CONCLUSIONS: The (18)F-FDG uptake ratio is higher than that of (18)F-FLT in A549 cells at the cellular level. (18)F-FLT imaging might be superior for the quantitative diagnosis of lung tumor tissue and could distinguish lung cancer nodules from other SPNs.
format Online
Article
Text
id pubmed-5198527
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-51985272017-01-19 Comparison of Positron Emission Tomography Using 2-[(18)F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[(18)F]-fluorothymidine in Lung Cancer Imaging Wang, Fu-Li Tan, Ye-Ying Gu, Xiang-Min Li, Tian-Ran Lu, Guang-Ming Liu, Gang Huo, Tian-Long Chin Med J (Engl) Original Article BACKGROUND: The detection of solitary pulmonary nodules (SPNs) that may potentially develop into a malignant lesion is essential for early clinical interventions. However, grading classification based on computed tomography (CT) imaging results remains a significant challenge. The 2-[(18)F]-fluoro-2-deoxy-D-glucose ((18)F-FDG) positron emission tomography (PET)/CT imaging produces both false-positive and false-negative findings for the diagnosis of SPNs. In this study, we compared (18)F-FDG and 3-deoxy-3-[(18)F]-fluorothymidine ((18)F-FLT) in lung cancer PET/CT imaging. METHODS: The binding ratios of the two tracers to A549 lung cancer cells were calculated. The mouse lung cancer model was established (n = 12), and micro-PET/CT analysis using the two tracers was performed. Images using the two tracers were collected from 55 lung cancer patients with SPNs. The correlation among the cell-tracer binding ratios, standardized uptake values (SUVs), and Ki-67 proliferation marker expression were investigated. RESULTS: The cell-tracer binding ratio for the A549 cells using the (18)F-FDG was greater than the ratio using (18)F-FLT (P < 0.05). The Ki-67 expression showed a significant positive correlation with the (18)F-FLT binding ratio (r = 0.824, P < 0.01). The tumor-to-nontumor uptake ratio of (18)F-FDG imaging in xenografts was higher than that of (18)F-FLT imaging. The diagnostic sensitivity, specificity, and the accuracy of (18)F-FDG for lung cancer were 89%, 67%, and 73%, respectively. Moreover, the diagnostic sensitivity, specificity, and the accuracy of (18)F-FLT for lung cancer were 71%, 79%, and 76%, respectively. There was an obvious positive correlation between the lung cancer Ki-67 expression and the mean maximum SUV of (18)F-FDG and (18)F-FLT (r = 0.658, P < 0.05 and r = 0.724, P < 0.01, respectively). CONCLUSIONS: The (18)F-FDG uptake ratio is higher than that of (18)F-FLT in A549 cells at the cellular level. (18)F-FLT imaging might be superior for the quantitative diagnosis of lung tumor tissue and could distinguish lung cancer nodules from other SPNs. Medknow Publications & Media Pvt Ltd 2016-12-20 /pmc/articles/PMC5198527/ /pubmed/27958224 http://dx.doi.org/10.4103/0366-6999.195468 Text en Copyright: © 2016 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Wang, Fu-Li
Tan, Ye-Ying
Gu, Xiang-Min
Li, Tian-Ran
Lu, Guang-Ming
Liu, Gang
Huo, Tian-Long
Comparison of Positron Emission Tomography Using 2-[(18)F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[(18)F]-fluorothymidine in Lung Cancer Imaging
title Comparison of Positron Emission Tomography Using 2-[(18)F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[(18)F]-fluorothymidine in Lung Cancer Imaging
title_full Comparison of Positron Emission Tomography Using 2-[(18)F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[(18)F]-fluorothymidine in Lung Cancer Imaging
title_fullStr Comparison of Positron Emission Tomography Using 2-[(18)F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[(18)F]-fluorothymidine in Lung Cancer Imaging
title_full_unstemmed Comparison of Positron Emission Tomography Using 2-[(18)F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[(18)F]-fluorothymidine in Lung Cancer Imaging
title_short Comparison of Positron Emission Tomography Using 2-[(18)F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[(18)F]-fluorothymidine in Lung Cancer Imaging
title_sort comparison of positron emission tomography using 2-[(18)f]-fluoro-2-deoxy-d-glucose and 3-deoxy-3-[(18)f]-fluorothymidine in lung cancer imaging
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198527/
https://www.ncbi.nlm.nih.gov/pubmed/27958224
http://dx.doi.org/10.4103/0366-6999.195468
work_keys_str_mv AT wangfuli comparisonofpositronemissiontomographyusing218ffluoro2deoxydglucoseand3deoxy318ffluorothymidineinlungcancerimaging
AT tanyeying comparisonofpositronemissiontomographyusing218ffluoro2deoxydglucoseand3deoxy318ffluorothymidineinlungcancerimaging
AT guxiangmin comparisonofpositronemissiontomographyusing218ffluoro2deoxydglucoseand3deoxy318ffluorothymidineinlungcancerimaging
AT litianran comparisonofpositronemissiontomographyusing218ffluoro2deoxydglucoseand3deoxy318ffluorothymidineinlungcancerimaging
AT luguangming comparisonofpositronemissiontomographyusing218ffluoro2deoxydglucoseand3deoxy318ffluorothymidineinlungcancerimaging
AT liugang comparisonofpositronemissiontomographyusing218ffluoro2deoxydglucoseand3deoxy318ffluorothymidineinlungcancerimaging
AT huotianlong comparisonofpositronemissiontomographyusing218ffluoro2deoxydglucoseand3deoxy318ffluorothymidineinlungcancerimaging